Johnson & Johnson 2Q results could beat even as pharma sales weigh
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
148,960€
1,14%
Echtzeit-Aktienkurs Johnson & Johnson
Bid:
Ask:
Nachrichten zur Johnson & Johnson Aktie
Nanobiotix Shares Soar on Licensing Deal With J&J Unit >NBTX
Nanobiotix Shares Soar on Licensing Deal With J&J Unit >NBTX...…
NANOBIOTIX Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3
PARIS and CAMBRIDGE, Mass., July 10, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the…
Is Johnson & Johnson Stock a Buy Now?
Some businesses never go out of style....…
Is Johnson & Johnson Stock a Buy?
Lets take a look at this Dividend King after its spin-off of Kenvue and its proposed $8.7 billion litigation settlement....…
2 Reasons to Buy Johnson & Johnson, and 1 Reason to Sell
This pharma company has reached an important transition point....…
Bausch + Lomb Buys Blink Eye Drop From J&J for $106.5M
Bausch + Lomb Buys Blink Eye Drop From J&J for $106.5M...…
Protagonist Therapeutics-Janssen Partnered Psoriasis Candidate Fall Short Of Rival Treatment
Protagonist Therapeutics Inc (NASDAQ: PTGX) announced topline results from the Phase 2b FRONTIER 1 trial of the oral interleukin-23 receptor (IL-23R)…
Protagonist Therapeutics, Inc.: Protagonist Therapeutics Announces Positive Topline Results with JNJ-2113, the First and Only Oral IL-23 Receptor Antagonist Peptide in Development for Moderate-to-Severe Plaque Psoriasis
Phase 2b FRONTIER 1 data presentation at World Congress of Dermatology highlights that a greater proportion of patients achieved 75,…
Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know
Johnson & Johnson (JNJ) closed at $163.35 in the latest trading session, marking a -1.31% move from the prior day....…
Johnson & Johnson psoriasis pill disappoints in phase 2 trial
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
J&J Fights to Save Legal Strategy That Would End Cancer Lawsuits
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Check Out What Whales Are Doing With JNJ
read more...…
Johnson & Johnson: Langfristig interessant - Aktienanalyse
Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär":
Jürgen Dreifürst vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die…
Is Johnson & Johnson Stock a Strong Buy?
The healthcare giant should deliver strong returns for shareholders over the long term....…
Where Will Johnson & Johnson Be in 5 Years?
The stocks returns over the past decade havent been great -- should investors expect that to change?...…
Biden Admin Stiffing COVID Vaccine-Injured Americans Over Medical Claims
Biden Admin Stiffing COVID Vaccine-Injured Americans Over Medical Claims
…
Appia Bio Expands Leadership Team With Sylvaine Cases, Ph.D. Appointed Chief Business Officer and Alex Babayan, Ph.D. as Vice President, Head of Regulatory Affairs
Dr. Cases is a proven life sciences leader with more than 20 years business development and R&D experience including Johnson…
SonoThera™ Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
Zimmermann brings more than two decades of experience in business development, merger and acquisition strategy, deals and partnership development. Prior…
California man tells jury of getting cancer after using J&J baby powder
...By Brendan Pierson
June 26 (Reuters) - A California man suing Johnson......…
Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know
Johnson & Johnson (JNJ) closed the most recent trading day at $163.63, moving -1.12% from the previous trading session....…
Dow falls 109 points on losses for Amgen, Johnson & Johnson shares
Dow falls 109 points on losses for Amgen, Johnson & Johnson shares...…
J&J talc bankruptcy unit to establish $750M trust fund with insurers
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Cramer says J&J stock is a coiled spring
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET....…
Will Johnson & Johnson Be a Trillion-Dollar Stock by 2038?
The healthcare company is already almost halfway there....…
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…
Immix Biopharma Subsidiary Nexcella Appoints Mary Sue Coleman, former Johnson & Johnson Independent Director, to Board of Directors
Um den gesamten Artikel unter globenewswire.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson wins conditional nod for prostate cancer therapy in Canada
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The Zacks Analyst Blog Highlights Johnson & Johnson, Oracle, HSBC, NVIDIA and The Cigna Group
Johnson & Johnson, Oracle, HSBC, NVIDIA and The Cigna Group are part of the Zacks top Analyst Blog....…
Could Johnson & Johnson Stock Help You Become a Millionaire?
A fantastic dividend stock with promising opportunities ahead, is it also a no-brainer buy for growth-oriented investors?...…
Top Research Reports for Johnson & Johnson, Oracle & HSBC
Todays Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Oracle Corporation (ORCL) and…
Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®
REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO),…
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what…
Alkermes Raises FY23 Guidance With Final Award In Johnson & Johnson Unit Arbitration
NEW BRUNSWICK (dpa-AFX) - Biopharmaceutical company Alkermes plc (ALKS) on Tuesday raised its fiscal 2023 earnings and revenue forecast after…
Alkermes lifts outlook after arbitration payment from Johnson & Johnson
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know
Johnson & Johnson (JNJ) closed at $158.32 in the latest trading session, marking a +0.86% move from the prior day....…
Analysis-Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast
...By Patrick Wingrove
(Reuters) - Johnson & Johnsons legal... pharmaceutical business in 2022.
Analysts told Reuters…
ANALYSIS-Stelara patent deal puts J&J back on path to $57 bln 2025 revenue forecast
...By Patrick Wingrove
June 5 (Reuters) - Johnson & Johnsons legal... pharmaceutical business
in 2022.
Analysts told Reuters the Stelara deal......…
Zimbabwe bans imports of J&J baby powder on concerns over talc
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Zimbabwe Bans Imports of J&J Baby Powder on Concerns Over Talc
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
J&J strebt Bewertung von bis zu 43 Milliarden für Verbrauchergeschäft an
Frankfurt (Reuters) - Der US-Pharmakonzern Johnson & Johnson strebt beim geplanten Börsengang seines Geschäfts mit rezeptfreien Gesundheitsprodukten eine Bewertung von…
Johnson & Johnson hebt Jahresziele an - Quartalsverlust nach Milliardenvergleich
NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Konsumgüterkonzern Johnson & Johnson ist besser als erwartet…
J&J-Tochterfirma beantragt erneut Gläubigerschutz im Babypuder-Skandal
New York (Reuters) - Eine Tochterfirma des US-Pharma- und Konsumgüterherstellers Johnson & Johnson (J&J) hat im Skandal um mutmaßlich asbestverseuchtes…
Johnson & Johnson will 'Baby Powder'-Klagen mit Milliarden-Vergleich beilegen
NEW BRUNSWICK (dpa-AFX) - Der US-Pharmakonzern Johnson & Johnson (J&J) will einen großen Rechtsstreit um…
Gericht verpasst Johnson & Johnson Dämpfer um krebsverdächtiges Babypuder
NEW BRUNSWICK (dpa-AFX) - Der US-Pharma- und Konsumgüterkonzern Johnson & Johnson hat im Zusammenhang mit…
Johnson & Johnson verfehlt 2022 eigene Wachstumsziele
NEW BRUNSWICK (dpa-AFX) - Weniger verkaufte Covid-Impfungen und der starke Dollar haben den Pharma- und Konsumgüterkonzern…
Johnson & Johnson: Aussichtsreicher HIV-Impfstoff schützt nicht
BERLIN (dpa-AFX) - Ein besonders aussichtsreicher Impfstoffkandidat gegen die Immunschwächekrankheit Aids schützt nicht ausreichend vor einer…
Johnson&Johnson-Sparte Kenvue stellt Antrag auf Börsennotierung
Bangalore (Reuters) - Die Consumer-Health-Sparte mit rezeptfreien Medikamenten und anderen Gesundheitsprodukten des US-Pharmakonzerns Johnson & Johnson (J&J) hat einen Antrag…
Gesundheitskonzern Johnson & Jonson spürt Gegenwind durch starken Dollar
NEW BRUNSWICK (dpa-AFX) - Der Gegenwind durch den starken US-Dollar hat den Gesundheitskonzern Johnson & Johnson…
US-Gesundheitskonzern Johnson & Johnson senkt wegen Dollarstärke Prognose
NEW BRUNSWICK (dpa-AFX) - Der starke Dollar bremst den Gesundheitskonzern Johnson & Johnson . Für das…